Roivant Sciences Ltd.
ROIV
$10.66
$0.242.30%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
1/28/2025
-
MarketBeat
3/14/2025
-
Ticker Report
3/7/2025
-
Insider Monkey
3/6/2025
-
The Online Investor
3/6/2025
-
MarketBeat
3/5/2025
-
Ticker Report
3/5/2025
-
MarketBeat
3/4/2025
-
Tickeron - Stocks
3/3/2025
-
Insider Monkey
3/3/2025
-
Insider Monkey
3/2/2025
-
Ticker Report
2/28/2025
-
MarketBeat
2/27/2025
-
MarketBeat
2/26/2025
-
MarketBeat
2/25/2025
-
The Fly
2/25/2025
-
Globe Newswire
2/25/2025
-
MarketBeat
2/22/2025
-
MarketBeat
2/21/2025
-
TipRanks Financial Blog
2/20/2025
-
MarketBeat
2/19/2025
-
MarketBeat
2/16/2025
-
Ticker Report
2/16/2025
-
MarketBeat
2/15/2025
-
MarketBeat
2/14/2025
-
GuruFocus
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Monday, February 10, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 26 and 30 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
44 20 7400 3347
Address
50 Broadway
London, SW1H 0DB
London, SW1H 0DB
Country
Year Founded
Business Description
Sector
Roivant Sciences Ltd., a commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for inflammation and immunology areas. The company provides...
more
